Publication | Closed Access

Safety, tolerability, pharmacokinetics, and antimalarial efficacy of a novel Plasmodium falciparum ATP4 inhibitor SJ733: a first-in-human and induced blood-stage malaria phase 1a/b trial

Antiparasitic AgentMedicineMalariaAntimalarial EfficacyPharmacotherapyPharmacologyParasite GenomicsDrug Discovery